Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Change in Accured Expenses (2016 - 2017)

Historic Change in Accured Expenses for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to -$1.0 million.

  • Eledon Pharmaceuticals' Change in Accured Expenses fell 903636.36% to -$1.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$845000.0, marking a year-over-year decrease of 20193.0%. This contributed to the annual value of $2.1 million for FY2022, which is 289.31% down from last year.
  • Per Eledon Pharmaceuticals' latest filing, its Change in Accured Expenses stood at -$1.0 million for Q3 2017, which was down 903636.36% from -$368000.0 recorded in Q2 2017.
  • In the past 5 years, Eledon Pharmaceuticals' Change in Accured Expenses ranged from a high of $1.3 million in Q4 2014 and a low of -$1.2 million during Q1 2015
  • In the last 5 years, Eledon Pharmaceuticals' Change in Accured Expenses had a median value of $86500.0 in 2014 and averaged $76437.5.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 522500.0% in 2015, then tumbled by 903636.36% in 2017.
  • Over the past 5 years, Eledon Pharmaceuticals' Change in Accured Expenses (Quarter) stood at -$464000.0 in 2013, then soared by 379.53% to $1.3 million in 2014, then dropped by 19.28% to $1.0 million in 2015, then plummeted by 85.39% to $153000.0 in 2016, then plummeted by 756.86% to -$1.0 million in 2017.
  • Its Change in Accured Expenses was -$1.0 million in Q3 2017, compared to -$368000.0 in Q2 2017 and $375000.0 in Q1 2017.